Abeona Therapeutics reports 2024 financial results

Abeona Therapeutics Inc. held a conference call on March 20, 2025, to discuss its financial results for the full year 2024. The call started with a welcome from Greg Gin, the Vice President of Investor Relations and Communications. During the call, company leaders listed several financial highlights and business updates. They emphasized that some comments made could include forward-looking statements. These statements are based on the company's expectations, but actual results may differ due to various risk factors. CEO Dr. Vish Seshadri, along with other executives, provided insights into the company’s performance and future plans. They detailed the achievements and challenges Abeona faced over the past year. The full set of financial results and further information were shared through a press release and are available on their website. Investors and analysts participated in the call, asking questions about the company's strategy and market outlook. The discussions aimed to give a clearer picture of Abeona's progress and potential as a biopharmaceutical company.